본문 바로가기
KERD
논문KCI 등재

Neurological Manifestations in Patients with COVID-19: Experiences from the Central Infectious Diseases Hospital in South Korea

이서영|김현경|조여정
대한신경과학회 (Korean Neurological Association)|2021.07|Journal of Clinical Neurology|제17권 제3호|pp. 435-442|DOI 10.3988/jcn.2021.17.3.435

1

조회

0

다운로드

4

인용

0

참고문헌

키워드

COVID-19Korea.neurological manifestations

초록

Background and Purpose To investigate the incidence and characteristics of neurological manifestations associated with coronavirus disease 2019 (COVID-19). Methods We reviewed the medical records of the consecutive patients with COVID-19 who were admitted to the central infectious diseases hospital designated for the treatment of COVID- 19 in South Korea between March 2020 and September 2020. Newly developed neurological manifestations associated with COVID-19 were investigated. The frequency and clinical features of the neurological manifestations were analyzed according to disease severity, which was classified according to World Health Organization interim guidance. Results Of the 306 symptomatic patients, 186 (60.8%) developed at least one neurological manifestation during hospitalization. The most common neurological symptom was headache (n=102, 33.3%), followed by myalgia (n=96, 31.4%) and anosmia/ageusia (n=54, 17.6%). Acute stroke (all ischemic stroke) occurred in three (1.0%) patients, and new-onset seizures occurred in two (0.7%). Neurological manifestation was a presenting symptom of COVID-19 in 72 (23.5%) patients, and was the only symptom of COVID-19 in 12 (3.9%). Stroke, seizure, and impaired consciousness were significantly associated with severe to critical COVID-19, whereas headache and anosmia/ageusia were frequently found in patients with mild to moderate disease. Conclusions Neurological manifestations were commonly observed in patients with COVID- 19. During the current pandemic, when patients present with new-onset neurological symptoms, COVID-19 may be considered as part of the differential diagnosis. Attention to severe neurological complications is needed, especially in patients with severe or critical COVID- 19.

Abstract

Background and Purpose To investigate the incidence and characteristics of neurological manifestations associated with coronavirus disease 2019 (COVID-19). Methods We reviewed the medical records of the consecutive patients with COVID-19 who were admitted to the central infectious diseases hospital designated for the treatment of COVID- 19 in South Korea between March 2020 and September 2020. Newly developed neurological manifestations associated with COVID-19 were investigated. The frequency and clinical features of the neurological manifestations were analyzed according to disease severity, which was classified according to World Health Organization interim guidance. Results Of the 306 symptomatic patients, 186 (60.8%) developed at least one neurological manifestation during hospitalization. The most common neurological symptom was headache (n=102, 33.3%), followed by myalgia (n=96, 31.4%) and anosmia/ageusia (n=54, 17.6%). Acute stroke (all ischemic stroke) occurred in three (1.0%) patients, and new-onset seizures occurred in two (0.7%). Neurological manifestation was a presenting symptom of COVID-19 in 72 (23.5%) patients, and was the only symptom of COVID-19 in 12 (3.9%). Stroke, seizure, and impaired consciousness were significantly associated with severe to critical COVID-19, whereas headache and anosmia/ageusia were frequently found in patients with mild to moderate disease. Conclusions Neurological manifestations were commonly observed in patients with COVID- 19. During the current pandemic, when patients present with new-onset neurological symptoms, COVID-19 may be considered as part of the differential diagnosis. Attention to severe neurological complications is needed, especially in patients with severe or critical COVID- 19.

참고문헌 (51)

  1. Ellul MA, "Neurological associations of COVID-19", Lancet Neurol, 19, pp.767~783 (2020)
  2. Mao L, "Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China", JAMA Neurol, 77, pp.683~690 (2020)
  3. Favas TT, "Neurological manifestations of COVID-19 : a systematic review and meta-analysis of proportions", Neurol Sci, 41, pp.3437~3470 (2020)
  4. Chen X, "A systematic review of neurological symptoms and complications of COVID-19", J Neurol, 268, pp.392~402 (2021)
  5. Baig AM, "Evidence of the COVID-19 virus targeting the CNS : tissue distribution, host-virus interaction, and proposed neurotropic mechanisms", ACS Chem Neurosci, 11, pp.995~998 (2020)
  6. "Coronavirus Disease-19, Republic of Korea: latest updates" (2020)[URL]
  7. 권두혁, "Characteristics of Acute Stroke in Patients with Coronavirus Disease 2019 and Challenges in Stroke Management during an Epidemic", Journal of Korean Medical Science, 35(35), pp.1~7 (2020), 대한의학회[DOI]
  8. Yonghyun Lee, "Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients", Journal of Korean Medical Science, 35(18), pp.1~6 (2020), 대한의학회[DOI]
  9. "COVID-19 clinical management: interim guidance" (2020)[URL]
  10. "COVID-19" (2020)[URL]
  11. Agarwal P, "Neurological manifestations in 404 COVID-19 patients in Washington State", J Neurol, 268, pp.770~772 (2021)
  12. Kacem I, "Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19", Neurol Sci, 42, pp.39~46 (2021)
  13. Romero-Sánchez CM, "Neurologic manifestations in hospitalized patients with COVID-19 : the ALBACOVID registry", Neurology, 95, pp.e1060~ (2020)
  14. Campiglio L, "Neurological symptoms in acute COVID-19infected patients : a survey among Italian physicians", PLoS One, 15, pp.e0238159~ (2020)
  15. Frontera JA, "A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York city", Neurology, 96, pp.e575~ (2021)
  16. Kremer S, "Neurologic and neuroimaging findings in patients with COVID-19 : a retrospective multicenter study", Neurology, 95, pp.e1868~ (2020)
  17. Xiong W, "New onset neurologic events in people with COVID-19 in 3 regions in China", Neurology, 95, pp.e1479~ (2020)
  18. Paterson RW, "The emerging spectrum of COVID-19 neurology : clinical, radiological and laboratory findings", Brain, 143, pp.3104~3120 (2020)
  19. Meppiel E, "Neurologic manifestations associated with COVID-19 : a multicentre registry", Clin Microbiol Infect, 27, pp.458~466 (2021)
  20. Tancheva L, "Emerging neurological and psychobiological aspects of COVID-19 infection", Brain Sci, 10, pp.852~ (2020)
  21. Li YC, "The neuroinvasive potential of SARSCoV2 may play a role in the respiratory failure of COVID-19 patients", J Med Virol, 92, pp.552~555 (2020)
  22. Keyhanian K, "SARS-CoV-2 and nervous system : from pathogenesis to clinical manifestation", J Neuroimmunol, 350, pp.577436~ (2020)
  23. Yan CH, "Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms", Int Forum Allergy Rhinol, 10, pp.806~813 (2020)
  24. Lechien JR, "Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease(COVID-19) : a multicenter European study", Eur Arch Otorhinolaryngol, 277, pp.2251~2261 (2020)
  25. Yachou Y, "Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2 : understanding the neurological manifestations in COVID-19 patients", Neurol Sci, 41, pp.2657~2669 (2020)
  26. Le Guennec L, "Orbitofrontal involvement in a neuroCOVID-19 patient", Epilepsia, 61, pp.e90~ (2020)
  27. Moriguchi T, "A first case of meningitis", encephalitis associated with SARS-Coronavirus-2, 2020, pp.94, 55~58
  28. Paniz-Mondolfi A, "Central nervous system involvement by severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)", J Med Virol, 92, pp.699~702 (2020)
  29. Luigetti M, "Assessment of neurological manifestations in hospitalized patients with COVID-19", Eur J Neurol, 27, pp.2322~2328 (2020)
  30. Beltrán-Corbellini Á, "Acute-onset smell and taste disorders in the context of COVID-19 : a pilot multicentre polymerase chain reaction based case-control study", Eur J Neurol, 27, pp.1738~1741 (2020)
  31. Pormohammad A, "Comparison of influenza type A and B with COVID-19: a global systematic review and meta-analysis on clinical, laboratory and radiographic findings", Rev Med Virol, pp.e2179~ (2020)
  32. Headache Classification Committee of the International Headache Society(IHS), "The International Classification of Headache Disorders, 3rd edition", Cephalalgia, 38, pp.1~211 (2018)
  33. Bobker SM, "COVID-19 and headache : a primer for trainees", Headache, 60, pp.1806~1811 (2020)
  34. Islam MA, "Prevalence of headache in patients with coronavirus disease 2019(COVID-19) : a systematic review and meta-analysis of 14, 275 patients", Front Neurol, 11, pp.562634~ (2020)
  35. Monto AS, "Clinical signs and symptoms predicting influenza infection", Arch Intern Med, 160, pp.3243~3247 (2000)
  36. Yan CH, "Self-reported olfactory loss associates with outpatient clinical course in COVID-19", Int Forum Allergy Rhinol, 10, pp.821~831 (2020)
  37. Talavera B, "Anosmia is associated with lower inhospital mortality in COVID-19", J Neurol Sci, 419, pp.117163~ (2020)
  38. Agyeman AA, "Smell and taste dysfunction in patients with COVID-19 : a systematic review and meta-analysis", Mayo Clin Proc, 95, pp.1621~1631 (2020)
  39. Varga Z, "Endothelial cell infection and endotheliitis in COVID-19", Lancet, 395, pp.1417~1418 (2020)
  40. Salahuddin H, "Neurological predictors of clinical outcomes in hospitalized patients with COVID-19", Front Neurol, 11, pp.585944~ (2020)
  41. Merkler AE, "Risk of ischemic stroke in patients with coronavirus disease 2019(COVID-19)vs patients with influenza", JAMA Neurol, 77, pp.1366~1372 (2020)
  42. Piroth L, "Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza : a nationwide, population-based retrospective cohort study", Lancet Respir Med, 9, pp.251~259 (2021)
  43. Smeeth L, "Risk of myocardial infarction and stroke after acute infection or vaccination", N Engl J Med, 351, pp.2611~2618 (2004)
  44. Emsley HC, "Acute ischaemic stroke and infection : recent and emerging concepts", Lancet Neurol, 7, pp.341~353 (2008)
  45. Vohora D, "COVID-19 and seizures : Is there a link?", Epilepsia, 61, pp.1840~1853 (2020)
  46. Emami A, "Seizure in patients with COVID-19", Neurol Sci, 41, pp.3057~3061 (2020)
  47. Brad Tyson, "Altered mental status in 71 deaths due to COVID-19", International Journal of Neuroscience, pp.1~4 (2020), Informa UK Limited[DOI]
  48. Nersesjan V, "Thirty-day mortality and morbidity in COVID-19 positive vs. COVID-19 negative individuals and vs. individuals tested for influenza A", B: a population-based study, 2020, pp.7, 598272~
  49. Kaye R, "COVID-19 anosmia reporting tool : initial findings", Otolaryngol Head Neck Surg, 163, pp.132~134 (2020)
  50. Alberti P, "Guillain-Barré syndrome related to COVID-19 infection", Neurol Neuroimmunol Neuroinflamm, 7, pp.e741~ (2020)
  51. Oxley TJ, "Large-vessel stroke as a presenting feature of Covid-19 in the young", N Engl J Med, 382, pp.e60~ (2020)

관련 논문AI추천

COVID-19-Associated Encephalopathy: Systematic Review of Case ReportsAristo Pangestu, Vivien Puspitasari, Yusak Mangara Tua Siahaan대한신경과학회 · Journal of Clinical Neurology2022 · 제18권 제2호COVID-19 감염 후 발생한 두개뇌압 상승박우현, 송승원, 이정현, 정다은, 주민경대한신경과학회 · 대한신경과학회지2023 · 제41권 제2호Neurological Complications during Treatment of Middle East Respiratory Syndrome김민기, 김지은, 김혜옥, 박상순, 박태환, 송숙희, 안진영, 최재필, 허재혁대한신경과학회 · Journal of Clinical Neurology2017 · 제13권 제3호코로나19와 메르스 거점병원을 경험한 신경과 의사의 소회권두혁, 홍정호, 황지혜대한신경과학회 · 대한신경과학회지2020 · 제38권 제3호Neurological complications during the course of severe COVID-19: Is it just the tip of the iceberg?Arzu Topeli, Burcin Halacli, Gulcin Koc Yamanyar, Mehmet Yildirim대한중환자의학회 · Acute and Critical Care2022 · 제37권 제1호Stroke in Coronavirus Disease 2019: A Systematic ReviewDheeraj Khurana, M.V. Padma Srivastava, Radhakrishna Pedapati, Rohit bhatia, Snigdha Komakula, Sreenivas Vishnubhatla대한뇌졸중학회 · 대한뇌졸중영문학회지2020 · 제22권 제3호

이 간행물의 다른 논문 (26건)

Update on Nystagmus and Other Ocular Oscillations김지수, 정성해pp. 337-343Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia: The Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia Study나정호, 박만석, 구자성, 김응규, 박종무, 오미선, 황양하, 이경복, 방오영, 이수주, 배희준, 권순억, 손성일, 성상민, 차재관, 홍근식, 김범준, 이용석, 김용재, 박종호, 권지현, 최재철, 이경열, 하상원, 정진만, 안성환, 남효석pp. 344-353Development of the Parental Questionnaire for Cerebral Visual Impairment in Children Younger than 72 Months정희정, 변정해, 문진화, 은소희, 김성구, 김건하, 은백린, 염정숙, 김승효, 노병호, 김진경, 최지은, 김준식, 김영훈pp. 354-362Acute Confusion as an Initial Presentation of SARS-CoV-2 InfectionGeberhiwot Tarekegn, Sawlani Vijay, Gautam Nandan, Madathil Shyam, Dawson Charlotte, Ochoa-Ferraro Antonio, Butt Isabelpp. 363-367Impact of an Education Program for Caregivers of Patients with Alzheimer's Disease on Treatment Discontinuation and Compliance in Korea정지향, 윤수진, 김상윤, 최성혜, 김은주, 양영순, 강경훈, 장재원, 정슬기, 박기형, 김희진, 심용수, 이찬녕, 정산pp. 368-375
원문 보기